E
Emerson Clinical Research Institute | Falls Church, VA
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
APL-2
Pegcetacoplan
Bimatoprost
Elamipretide
Parent organization
This site is a part of Emerson Clinical Research Institute
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
2 of 3 total trials
This is a phase 3, open-label, multicenter, extension study to evaluate the long-term safety and efficacy of pegcetacoplan (APL-2) in subjects with g...
Active, not recruiting
Geographic Atrophy Secondary to Age-related Macular Degeneration
Drug: PEGCETACOPLAN (APL-2)
The goal of this clinical trial is to evaluate the efficacy, safety and pharmacokinetics of elamipretide in subjects with dry age-related macular deg...
Enrolling
Age-Related Macular Degeneration
Drug: Elamipretide
Drug: Placebo
Trial sponsors
A
Clinical trials
Research sites
Resources
Legal
© Copyright 2024 Veeva Systems